Beighton Score Calculator

Assess joint hypermobility using the standardized Beighton Score for EDS screening and connective tissue disorder evaluation.

Calculate the Beighton Score by evaluating 9 specific joint mobility tests. This validated clinical tool helps screen for Ehlers-Danlos Syndrome, hypermobility spectrum disorders, and other connective tissue conditions.

Clinical Examples

Click on any example to load it into the calculator.

Normal Joint Mobility

normal

Typical results for someone with normal joint flexibility and no hypermobility concerns.

Dorsiflexion: 0

Thumb Apposition: 0

Elbow Hyperextension: 0

Knee Hyperextension: 0

Forward Flexion: 0

Total Score: 0

Mild Hypermobility

mild

Moderate flexibility with some hypermobility but below clinical threshold for EDS.

Dorsiflexion: 1

Thumb Apposition: 0

Elbow Hyperextension: 1

Knee Hyperextension: 0

Forward Flexion: 1

Total Score: 3

Moderate Hypermobility

moderate

Significant hypermobility that meets criteria for hypermobility spectrum disorder.

Dorsiflexion: 1

Thumb Apposition: 1

Elbow Hyperextension: 1

Knee Hyperextension: 1

Forward Flexion: 1

Total Score: 5

Severe Hypermobility

severe

High score indicating probable Ehlers-Danlos Syndrome or severe hypermobility disorder.

Dorsiflexion: 1

Thumb Apposition: 1

Elbow Hyperextension: 1

Knee Hyperextension: 1

Forward Flexion: 1

Total Score: 5

Other Titles
Understanding Beighton Score Calculator: A Comprehensive Guide
Master the clinical assessment of joint hypermobility using the validated Beighton Score. Learn how to screen for Ehlers-Danlos Syndrome and hypermobility spectrum disorders with precision and accuracy.

What is the Beighton Score?

  • Clinical Definition and Purpose
  • Historical Development
  • Validation and Reliability
The Beighton Score is a standardized clinical assessment tool designed to evaluate joint hypermobility, a key feature of connective tissue disorders such as Ehlers-Danlos Syndrome (EDS) and hypermobility spectrum disorders. Developed by Professor Peter Beighton in the 1970s, this nine-point scoring system provides healthcare professionals with a reliable, reproducible method to quantify joint flexibility and identify individuals who may require further evaluation for underlying connective tissue conditions.
The Clinical Significance of Joint Hypermobility
Joint hypermobility, characterized by excessive range of motion beyond normal limits, serves as a crucial clinical marker for various connective tissue disorders. While some degree of flexibility is normal and even beneficial, excessive hypermobility can indicate underlying genetic conditions affecting collagen structure and function. The Beighton Score helps distinguish between normal flexibility and clinically significant hypermobility that warrants further investigation.
Components of the Beighton Score Assessment
The assessment consists of five specific maneuvers, each scored as 0 or 1 point: passive dorsiflexion of the 5th finger beyond 90 degrees (bilateral), thumb apposition to the forearm (bilateral), elbow hyperextension beyond 10 degrees (bilateral), knee hyperextension beyond 10 degrees (bilateral), and forward flexion with palms flat on the floor. The maximum possible score is 9, with higher scores indicating greater joint hypermobility.
Clinical Validation and Diagnostic Accuracy
Extensive research has validated the Beighton Score as a reliable screening tool with good sensitivity and specificity for identifying hypermobility spectrum disorders. Studies demonstrate that scores of 4 or higher have approximately 80-85% sensitivity for detecting clinically significant hypermobility, while scores of 6 or higher show strong correlation with confirmed EDS diagnoses. However, the tool should be used as part of a comprehensive clinical evaluation rather than as a standalone diagnostic test.

Key Clinical Thresholds:

  • Score 0-3: Normal joint mobility, no clinical concern
  • Score 4-5: Mild hypermobility, consider monitoring
  • Score 6-7: Moderate hypermobility, likely hypermobility spectrum disorder
  • Score 8-9: Severe hypermobility, probable EDS or severe connective tissue disorder

Step-by-Step Guide to Using the Beighton Score Calculator

  • Patient Preparation and Positioning
  • Test Administration Technique
  • Scoring and Documentation
Accurate administration of the Beighton Score requires careful attention to patient positioning, proper technique, and consistent scoring criteria. Follow this systematic approach to ensure reliable results that can guide clinical decision-making and patient management.
1. Patient Preparation and Environment Setup
Ensure the patient is comfortable, relaxed, and wearing appropriate clothing that allows full joint visualization. The examination room should be well-lit with adequate space for movement. Explain the purpose of each test to the patient and obtain informed consent. Position the patient in a seated or standing position as appropriate for each specific test, ensuring they understand they should not force any movement beyond their natural range.
2. Systematic Test Administration
Begin with passive dorsiflexion testing of the 5th finger, gently applying pressure to bend the finger backward. Test both hands and score 1 point if either finger achieves 90 degrees or more. For thumb apposition, ask the patient to bend their thumb backward to touch their forearm, scoring 1 point if either thumb can reach the forearm. Test elbow hyperextension by having the patient extend their arms fully, scoring 1 point if either elbow extends beyond 10 degrees from neutral.
3. Knee and Trunk Flexibility Assessment
For knee hyperextension testing, have the patient stand with knees fully extended, scoring 1 point if either knee extends beyond 10 degrees backward. Finally, assess forward flexion by asking the patient to bend forward with knees straight, attempting to place their palms flat on the floor. Score 1 point if they can achieve this position. Document each test result immediately to ensure accuracy.
4. Score Calculation and Clinical Interpretation
Sum all positive test results to obtain the total Beighton Score. Consider age-related changes, as hypermobility naturally decreases with age. In adults, scores of 4 or higher suggest clinically significant hypermobility, while in children and adolescents, the threshold may be higher (5-6 points). Document the complete assessment including any pain, instability, or other symptoms reported during testing.

Age-Adjusted Interpretation Guidelines:

  • Children (5-12 years): Score ≥6 suggests hypermobility
  • Adolescents (13-18 years): Score ≥5 suggests hypermobility
  • Adults (19-50 years): Score ≥4 suggests hypermobility
  • Older Adults (50+ years): Score ≥3 may be significant

Real-World Applications and Clinical Decision Making

  • EDS Screening and Diagnosis
  • Sports Medicine and Rehabilitation
  • Pediatric Development Assessment
The Beighton Score serves as a critical tool across multiple medical specialties, guiding diagnosis, treatment planning, and patient management in various clinical contexts.
Ehlers-Danlos Syndrome Screening and Diagnosis
Rheumatologists, geneticists, and primary care physicians use the Beighton Score as a first-line screening tool for EDS and other connective tissue disorders. Scores of 6 or higher, particularly when accompanied by other clinical features such as skin hyperextensibility, easy bruising, or family history, strongly suggest the need for genetic evaluation. The score helps determine which patients require referral to specialists and guides the selection of appropriate genetic testing panels.
Sports Medicine and Physical Therapy Applications
Sports medicine physicians and physical therapists use the Beighton Score to assess injury risk and guide exercise prescription. Hypermobile athletes may require modified training programs that focus on joint stability and proprioception rather than flexibility. The score helps identify patients who may benefit from specific strengthening exercises, bracing recommendations, or activity modifications to prevent joint injuries and chronic pain.
Pediatric Development and Growth Monitoring
Pediatricians and developmental specialists use the Beighton Score to monitor joint development in children, particularly those with developmental delays or suspected connective tissue disorders. Early identification of hypermobility can guide appropriate interventions, including physical therapy, occupational therapy, and family education about joint protection strategies. The score helps distinguish between normal developmental flexibility and clinically significant hypermobility requiring intervention.

Clinical Decision Framework:

  • Score 0-3: No further evaluation needed unless other symptoms present
  • Score 4-5: Monitor for symptoms, consider basic joint protection education
  • Score 6-7: Refer to rheumatology/genetics, implement joint protection strategies
  • Score 8-9: Urgent specialist referral, comprehensive connective tissue evaluation

Common Misconceptions and Best Practices

  • Myth vs Reality in Hypermobility Assessment
  • Limitations and Considerations
  • Integration with Comprehensive Evaluation
Effective use of the Beighton Score requires understanding its limitations and avoiding common pitfalls that can lead to misinterpretation or inappropriate clinical decisions.
Myth: High Beighton Score Always Indicates EDS
This misconception can lead to overdiagnosis and unnecessary anxiety. Reality: While high scores (6-9) increase the likelihood of connective tissue disorders, they are not diagnostic alone. Many individuals with high scores have benign joint hypermobility syndrome without underlying genetic conditions. The score must be interpreted in context with other clinical features, family history, and associated symptoms such as chronic pain, joint instability, or skin manifestations.
Limitations and Important Considerations
The Beighton Score has several limitations: it doesn't assess all joints, may miss localized hypermobility, and doesn't account for pain or functional limitations. Age significantly affects scores, with natural decreases in flexibility occurring with aging. The tool doesn't distinguish between different types of EDS or other connective tissue disorders. Additionally, cultural and ethnic variations in joint flexibility may affect interpretation, requiring consideration of population-specific norms.
Integration with Comprehensive Clinical Evaluation
Best practice involves using the Beighton Score as part of a comprehensive evaluation that includes detailed medical history, family history, physical examination for other connective tissue features, and consideration of associated conditions. The score should be combined with assessment of symptoms such as chronic pain, joint instability, easy bruising, and skin hyperextensibility. When indicated, genetic testing and imaging studies provide additional diagnostic information.

Best Practice Principles:

  • Comprehensive Assessment: Combine Beighton Score with full clinical evaluation
  • Age-Appropriate Interpretation: Consider normal age-related changes in flexibility
  • Symptom Correlation: Evaluate hypermobility in context of patient symptoms
  • Family History: Include family history of connective tissue disorders in assessment

Mathematical Derivation and Clinical Research

  • Scoring Algorithm and Validation
  • Statistical Analysis and Population Studies
  • Future Directions and Research
The mathematical foundation of the Beighton Score reflects decades of clinical research and validation studies that have established its reliability and clinical utility across diverse populations.
Scoring Algorithm and Mathematical Basis
The Beighton Score uses a simple additive model where each positive test contributes 1 point to the total score. This binary scoring system (0 or 1) ensures consistency and reduces inter-rater variability. The choice of nine tests reflects clinical experience showing these joints provide the most reliable indicators of generalized hypermobility. The threshold of 4 points for adults represents the 95th percentile of normal joint flexibility in population studies.
Validation Studies and Diagnostic Accuracy
Multiple validation studies have demonstrated the Beighton Score's reliability with inter-rater correlation coefficients of 0.85-0.92. Sensitivity for detecting hypermobility spectrum disorders ranges from 75-85%, with specificity of 80-90%. The tool shows good correlation with other hypermobility assessment methods and demonstrates predictive value for identifying patients who will develop symptoms of connective tissue disorders over time.
Population Studies and Normative Data
Large population studies have established age and gender-specific normative values for the Beighton Score. Women typically score 1-2 points higher than men, and scores decrease by approximately 0.5 points per decade after age 20. Ethnic variations exist, with some populations showing higher baseline flexibility. These normative data help clinicians interpret scores appropriately for different patient populations.

Research-Based Thresholds:

  • General Population: 95th percentile = 4 points
  • Female Adults: 95th percentile = 5 points
  • Male Adults: 95th percentile = 3 points
  • Children (5-12): 95th percentile = 6 points